0001035267-24-000087.txt : 20240229 0001035267-24-000087.hdr.sgml : 20240229 20240229191715 ACCESSION NUMBER: 0001035267-24-000087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240228 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOHR MARSHALL CENTRAL INDEX KEY: 0001252986 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30713 FILM NUMBER: 24706221 MAIL ADDRESS: STREET 1: C/O INTUITIVE SURGICAL, INC STREET 2: 1266 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC CENTRAL INDEX KEY: 0001035267 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770416458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085232100 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-02-28 0 0001035267 INTUITIVE SURGICAL INC ISRG 0001252986 MOHR MARSHALL 1020 KIFER ROAD SUNNYVALE CA 94086 0 1 0 0 Executive VP Global Business S 1 Common Stock 2024-02-28 4 M 0 13530 242.3367 A 40407 D Common Stock 2024-02-28 4 S 0 13530 385.0805 D 26877 D Common Stock 2024-02-28 4 M 0 13530 177.9867 A 40407 D Common Stock 2024-02-28 4 S 0 13530 385.0805 D 26877 D Common Stock 2024-02-28 4 M 0 10500 166.6233 A 37377 D Common Stock 2024-02-28 4 S 0 10500 385.0805 D 26877 D Common Stock 2024-02-28 4 M 0 12750 174.2567 A 39627 D Common Stock 2024-02-28 4 S 0 12750 385.0805 D 26877 D Common Stock 2024-02-28 4 M 0 12750 139.52 A 39627 D Common Stock 2024-02-28 4 S 0 12750 385.0805 D 26877 D Common Stock 2024-02-28 4 M 0 22500 109.4856 A 49377 D Common Stock 2024-02-28 4 S 0 14620 385.0919 D 34757 D Common Stock 2024-02-28 4 M 0 22500 79.6378 A 57257 D Common Stock 2024-02-28 4 S 0 13750 385.0794 D 43507 D Common Stock 2024-02-28 4 M 0 11250 76.9989 A 54757 D Common Stock 2024-02-28 4 S 0 6860 385.0815 D 47897 D Common Stock 2024-02-28 4 M 0 10500 182.8333 A 58397 D Common Stock 2024-02-28 4 S 0 10500 385.0805 D 47897 D Common Stock 2024-02-29 4 M 0 2253 0.0 A 50150 D Common Stock 2024-02-29 4 F 0 1142 386.59 D 49008 D Common Stock 2024-02-29 4 M 0 1003 0.0 A 50011 D Common Stock 2024-02-29 4 F 0 509 386.59 D 49502 D Common Stock 100353 I by Trust Non-Qualified Stock Option (right to buy) 76.9989 2024-02-28 4 M 0 11250 0.0 D 2026-08-15 Common Stock 11250 0 D Non-Qualified Stock Option (right to buy) 79.6378 2024-02-28 4 M 0 22500 0.0 D 2027-02-15 Common Stock 22500 0 D Non-Qualified Stock Option (right to buy) 109.4856 2024-02-28 4 M 0 22500 0.0 D 2027-08-15 Common Stock 22500 0 D Non-Qualified Stock Option (right to buy) 139.52 2024-02-28 4 M 0 12750 0.0 D 2028-02-15 Common Stock 12750 0 D Non-Qualified Stock Option (right to buy) 166.6233 2024-02-28 4 M 0 10500 0.0 D 2029-08-15 Common Stock 10500 0 D Non-Qualified Stock Option (right to buy) 174.2567 2024-02-28 4 M 0 12750 0.0 D 2028-08-15 Common Stock 12750 0 D Non-Qualified Stock Option (right to buy) 177.9867 2024-02-28 4 M 0 13530 0.0 D 2030-02-28 Common Stock 13530 0 D Non-Qualified Stock Option (right to buy) 182.8333 2024-02-28 4 M 0 10500 0.0 D 2029-02-15 Common Stock 10500 0 D Non-Qualified Stock Option (right to buy) 242.3367 2024-02-28 4 M 0 13530 0.0 D 2030-08-28 Common Stock 13530 0 D Restricted Stock Units 0.0 2024-02-29 4 M 0 2253 0.0 D 2024-02-28 Common Stock 2253 0 D Restricted Stock Units 0.0 2024-02-29 4 M 0 1003 0.0 D 2026-02-28 Common Stock 1003 2004 D These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 15, 2024. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,620 shares sold at $383.85 to $384.82; 10,760 shares sold at $384.87 to $385.85; and 240 shares sold at $385.90 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,390 shares sold at $383.85 to $384.82; 10,116 shares sold at $384.87 to $385.79; and 244 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 1,574 shares sold at $383.85 to $384.73; 5,144 shares sold at $384.87 to $385.79; and 142 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. By: Donna Spinola For: Mohr, Marshall L 2024-02-29